The objective of this study was to assess the MV weaning rate and outcome of rescue or maintenance therapy with EGFR TKIs for stage IIIb-IV non-squamous NSCLC in Asian patients requiring MV. This evidence concerns the gene EGFR and non-small cell lung carcinoma.